American Bio Medica Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
8,894.00
7,285.00
6,317.00
5,609.00
4,914.00
3,872
Cost of Goods Sold (COGS) incl. D&A
5,322.00
4,223.00
3,462.00
3,119.00
2,917.00
2,584
Gross Income
3,572.00
3,062.00
2,855.00
2,490.00
1,997.00
1,288
SG&A Expense
4,703.00
3,187.00
2,868.00
2,747.00
2,308.00
2,050
EBIT
1,131.00
125.00
-
257.00
311.00
762
Unusual Expense
-
92.00
-
-
-
-
Non Operating Income/Expense
653.00
27.00
102.00
200.00
38.00
19
Interest Expense
310.00
244.00
420.00
284.00
272.00
284
Pretax Income
786.00
488.00
331.00
341.00
545.00
1,026
Income Tax
2.00
2.00
2.00
4.00
-
2
Consolidated Net Income
788.00
490.00
333.00
345.00
545.00
1,028
Net Income
788.00
490.00
333.00
345.00
545.00
1,028
Net Income After Extraordinaries
788.00
490.00
333.00
345.00
545.00
1,028
Net Income Available to Common
788.00
490.00
333.00
345.00
545.00
1,028
EPS (Basic)
0.04
0.02
0.01
0.01
0.02
0.03
Basic Shares Outstanding
22,270.60
23,336.80
25,677.00
27,463.30
29,211.50
30,115.10
EPS (Diluted)
0.04
0.02
0.01
0.01
0.02
0.03
Diluted Shares Outstanding
22,270.60
23,336.80
25,677.00
27,463.30
29,211.50
30,115.10
EBITDA
1,015.00
14.00
78.00
166.00
231.00
681
Non-Operating Interest Income
2.00
-
-
-
-
1
About American Bio Medica
View Profile
